|
RAD50 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.446100E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.380200E-02 |
| Normal-vs-Stage2 |
5.960800E-01 |
| Normal-vs-Stage3 |
2.488000E-01 |
| Normal-vs-Stage4 |
8.671200E-01 |
| Stage1-vs-Stage2 |
6.214600E-01 |
| Stage1-vs-Stage3 |
7.854400E-01 |
| Stage1-vs-Stage4 |
5.192600E-01 |
| Stage2-vs-Stage3 |
8.163400E-01 |
| Stage2-vs-Stage4 |
8.287200E-01 |
| Stage3-vs-Stage4 |
6.269200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.408000E-02 |
| Normal-vs-AfricanAmerican |
5.138000E-02 |
| Normal-vs-Asian |
5.059600E-01 |
| Caucasian-vs-AfricanAmerican |
5.837400E-01 |
| Caucasian-vs-Asian |
8.763600E-01 |
| AfricanAmerican-vs-Asian |
7.115800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.340150E-03 |
| Normal-vs-Female |
3.271800E-01 |
| Male-vs-Female |
5.617600E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.445600E-02 |
| Normal-vs-Extreme_Weight |
4.952500E-04 |
| Normal-vs-Obese |
5.186800E-01 |
| Normal-vs-Extreme_Obese |
3.950200E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.732600E-01 |
| Normal_Weight-vs-Obese |
3.287000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.082800E-01 |
| Extreme_Weight-vs-Obese |
3.070200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.122800E-01 |
| Obese-vs-Extreme_Obese |
6.427600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.365000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.673200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.557160E-03 |
| Normal-vs-Age(81-100Yrs) |
5.368400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.047400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.049790E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.782500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.054110E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.230630E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.676400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.575450E-03 |
| Normal-VS-Type2 PRCC |
5.733200E-01 |
| Normal-VS-KIRP CIMP |
9.431200E-01 |
| Normal-VS-Unclassified PRCC |
8.627800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.383900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.387000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.168360E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.719800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.069800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.600600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.924200E-02 |
| Normal-vs-N1 |
9.499000E-01 |
| Normal-vs-N2 |
3.559000E-01 |
| N0-vs-N1 |
1.194830E-01 |
| N0-vs-N2 |
8.456000E-01 |
| N1-vs-N2 |
2.758000E-01 |
|
|
